Target's General Information
Target ID T18299
Target Name CaM-kinase II (CAMK2)
Synonyms Calcium/calmodulin-dependent protein kinase type II; CaMK-II; CaM kinase II; CAMK
Target Type Clinical trial
Gene Name CAMK2A; CAMK2B; CAMK2D; CAMK2G
Biochemical Class Kinase
UniProt ID KCC2A_HUMAN||KCC2B_HUMAN||KCC2D_HUMAN||KCC2G_HUMAN
Target's Expression Profile in Disease Related Tissue between Patients and Normal People
Disease Rheumatoid arthritis
Example drug Rimacalib Phase 2 [1], [2], [3]
Tissue Synovial tissue
Level of differential expression between the patients in the disease section of the tissue and the tissues of healthy individual Fold-change: -0.33
Z-score: -0.93
P-value: 1.34E-02
Target gene expression profiles of the patients in the disease section of the tissue
Target gene expression profiles in the tissue of healthy individual
Target's Expression Profile across Various Tissues of Healthy Individual
References
REF 1 CaMKII inhibitors: from research tools to therapeutic agents. Front Pharmacol. 2014; 5: 21.
REF 2 Interpreting expression profiles of cancers by genome-wide survey of breadth of expression in normal tissues. Genomics 2005 Aug;86(2):127-41.
REF 3 NCBI GEO: archive for functional genomics data sets--update. Nucleic Acids Res. 2013 Jan;41(Database issue):D991-5.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.